English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

PerspectivesSecuring access to medicines and other health technologies in developing countries continues to be among the major challenges for global health. The challenge lies in ensuring that existing health products are delivered at afford-able prices and that innovations and discoveries meet the health needs of developing countries. This policy prob-lem calls for both global and national policy instruments. When in 2001 the Commission on Macroeconomics and Health categorized diseases as typeI, II and III based on the extent to which they affected countries at different eco-nomic levels, it was alienating for many public health professionals.

Securing the public good of health research and development for developing countries